Cytek Biosciences shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Cytek Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Cytek Biosciences held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytek Biosciences by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.0M | 880k | 9.12 |
| 2023-09-30 | $4.6M | 836k | 5.52 |
| 2023-06-30 | $6.0M | 700k | 8.54 |
| 2023-03-31 | $6.1M | 669k | 9.19 |
| 2022-12-31 | $6.8M | 668k | 10.21 |
| 2022-09-30 | $9.6M | 655k | 14.72 |
| 2022-06-30 | $3.4M | 315k | 10.73 |
| 2022-03-31 | $3.1M | 290k | 10.78 |
| 2021-12-31 | $1.7M | 106k | 16.33 |
| 2021-09-30 | $2.2M | 103k | 21.42 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management